Lo T K, Lau W L, Wong K S, Tang L C H
Department of Obstetrics and Gynaecology, Kwong Wah Hospital, 25 Waterloo Road, Hong Kong.
Hong Kong Med J. 2006 Oct;12(5):345-50.
To compare the efficacy of labour induction using sublingual misoprostol versus combined artificial rupture of membranes and oxytocin infusion for nulliparous women with a favourable cervix at term.
Open randomised controlled trial.
Regional hospital, Hong Kong.
Fifty nulliparous women with a favourable cervix (Bishop score 6 or more) at term and indications for labour induction.
With their informed consent, 100 eligible women were to be randomised to receive either sublingual misoprostol 50 micrograms every 4 hours for up to five doses or oxytocin infusion after artificial rupture of membranes. Interim analysis was planned at a sample size of 50.
Vaginal delivery within 24 hours of induction.
The study was terminated when interim analysis of the first 50 recruits showed that a significantly smaller proportion of misoprostol-treated women delivered vaginally within 24 hours of induction than in the conventional treatment group (68% vs 100%; relative risk, 0.68; 95% confidence interval, 0.51-0.91; P=0.009), although comparable numbers of women eventually delivered vaginally. The mean induction to vaginal delivery interval was 4.5 hours longer in the misoprostol group (P=0.027). After misoprostol treatment, all women went into labour. Forty percent of them delivered without oxytocin. There was no significant difference in uterine hyperstimulation rate, operative delivery rate, and neonatal outcomes. Maternal satisfaction was higher in the misoprostol group (92% vs 60%; relative risk, 1.53; 95% confidence interval, 1.09-2.16; P=0.008).
Despite being well accepted by women, labour induction using this regimen of sublingual misoprostol is less effective in achieving vaginal delivery within 24 hours.
比较足月时宫颈条件良好的初产妇使用舌下含服米索前列醇与联合人工破膜及缩宫素静脉滴注引产的效果。
开放性随机对照试验。
香港地区医院。
50名足月时宫颈条件良好(Bishop评分6分或更高)且有引产指征的初产妇。
在获得患者知情同意后,将100名符合条件的女性随机分为两组,一组每4小时舌下含服50微克米索前列醇,最多服用5剂;另一组在人工破膜后静脉滴注缩宫素。计划在样本量达到50时进行中期分析。
引产24小时内阴道分娩情况。
对首批50名招募对象进行中期分析时发现,米索前列醇治疗组在引产24小时内阴道分娩的女性比例显著低于传统治疗组(68%对100%;相对危险度为0.68;95%置信区间为0.51 - 0.91;P = 0.009),尽管最终两组阴道分娩的女性数量相当。米索前列醇组从引产到阴道分娩的平均间隔时间长4.5小时(P = 0.027)。米索前列醇治疗后,所有女性均开始分娩。其中40%的女性未使用缩宫素即分娩。两组在子宫过度刺激率、手术分娩率及新生儿结局方面无显著差异。米索前列醇组产妇满意度更高(92%对60%;相对危险度为1.53;95%置信区间为1.09 - 2.16;P = 0.008)。
尽管该舌下含服米索前列醇引产方案被女性广泛接受,但在24小时内实现阴道分娩方面效果较差。